Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 115 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

18%

21 trials in Phase 3/4

Results Transparency

0 of 66 completed trials have results

Key Signals

9 recruiting

Enrollment reporting

Analytics

N/A

47(51.1%)

Phase 4

17(18.5%)

Phase 2

13(14.1%)

Phase 1/2

9(9.8%)

Phase 3

4(4.3%)

Phase 2/3

1(1.1%)

Phase 1

1(1.1%)

92Total

N/A(47)

Phase 4(17)

Phase 2(13)

Phase 1/2(9)

+3 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (115)

Showing 20 of 115 trials

NCT07440186Not ApplicableRecruiting

Exploratory Clinical Research for the Evaluation of Human GMP (Good Manufacturing Practice) Collagen Implants (Humabiologics) in the Treatment of Corneal Melting (RCJ-COL3D-MC-01-2026)

Role: collaborator

NCT05871502Not ApplicableCompleted

Glycemia and Ischemia Reperfusion Brain Injury in Patients With Acute Cerebral Infarction Treated With Mechanical Thrombectomy

Role: lead

NCT07704164Phase 2Recruiting

Colchicine to Reduce Coronary Artery Inflammation in People With HIV

Role: lead

NCT07000526Phase 4Recruiting

Inhaled Sedation in Critically Ill Patients

Role: lead

NCT04001049Completed

Glycemic Variability: Prognostic Impact on Acute Ischemic Stroke

Role: lead

NCT07479927Not ApplicableRecruiting

Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy

Role: collaborator

NCT07194057Not Yet Recruiting

"A Privacy-protecting Environment for Child Transplants Health Related and Genomic Data Integration in the European Reference Network"

Role: lead

NCT06709469Phase 1Recruiting

Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults

Role: lead

NCT04230434Not ApplicableCompleted

Implementability and Effectiveness of the Safety Planning Intervention for Suicidal Behavior

Role: lead

NCT04555005Not ApplicableCompleted

Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19

Role: lead

NCT06701825Phase 4Recruiting

Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus

Role: lead

NCT03696654Not ApplicableActive Not Recruiting

High Blood Pressure in Paediatric Patients With Sleep Disorder Breathing.

Role: collaborator

NCT05983978Recruiting

No-biopsy Approach in Celiac Disease: Cut-off Points for IgA Anti-tissue Transglutaminase Assays

Role: lead

NCT04980326Not ApplicableCompleted

A Scalable Psychological Intervention to Reduce Psychological Distress Among Healthcare Workers

Role: lead

NCT05304754Phase 1/2Active Not Recruiting

"Phase I / II Study on Infusion of Natural Killer Cells After Haploidentical Transplantation in Pediatric Patients"

Role: lead

NCT06878742Phase 1/2Recruiting

Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants

Role: lead

NCT04265625Not ApplicableCompleted

Routine Use of FIBERoptic Bronchoscopic Guidance in Percutaneous TRACHeostomy

Role: lead

NCT04289493Not ApplicableCompleted

DUbbing Language-therapy CINEma-based in Aphasia Post-Stroke

Role: lead

NCT05250648Phase 4Recruiting

Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)

Role: collaborator

NCT05367427Not ApplicableCompleted

Heat-treated Postbiotic Consumption in Healthy People With Mild to Moderate Gastrointestinal Symptoms

Role: lead